Marcia Eisenberg - 04 Aug 2023 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Aug 2023
Net transactions value
$0
Form type
4
Filing time
08 Aug 2023, 16:23:33 UTC
Previous filing
16 Jun 2023
Next filing
31 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Stock Option (Right to Buy) Award $0 +148,000 $0.000000 148,000 04 Aug 2023 Common Stock 148,000 $0.7470 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person's continuing service, 1/3rd of such option grant will vest on the one year anniversary of the date of grant, with the remainder vesting in 24 equal monthly installments thereafter.